Synthesis and Characterization of 15N5-Labeled Aflatoxin B1–Formamidopyrimidines and Aflatoxin B1–N7-Guanine from a Partial Double-Stranded Oligodeoxynucleotide as Internal Standards for Mass Spectrometric Measurements
暂无分享,去创建一个
R. Lloyd | M. Dizdaroglu | C. Rizzo | P. Jaruga | M. Kant | Vladimir L Vartanian | M. Stone | R. Turesky | Rachana Tomar | Benjamin Sexton | Vladimir Vartanian | Vladimir L. Vartanian
[1] I. Minko,et al. DNA Sequence Modulates the Efficiency of NEIL1-Catalyzed Excision of the Aflatoxin B1-Induced Formamidopyrimidine Guanine Adduct. , 2021, Chemical research in toxicology.
[2] J. Essigmann,et al. Chapter 25. Mutational Spectra Provide Insight into the Mechanisms Bridging DNA Damage to Genetic Disease , 2020 .
[3] M. Egli,et al. Recognition of DNA adducts by edited and unedited forms of DNA glycosylase NEIL1. , 2019, DNA repair.
[4] M. Egli,et al. Characterization of rare NEIL1 variants found in East Asian populations. , 2019, DNA repair.
[5] R. Lloyd,et al. Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis. , 2019, DNA repair.
[6] R. Lloyd,et al. Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo as Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution. , 2018, Chemical research in toxicology.
[7] J. Essigmann,et al. Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B1 as a case study. , 2018, DNA repair.
[8] C. Marsden,et al. The NEIL1 G83D germline DNA glycosylase variant induces genomic instability and cellular transformation , 2017, Oncotarget.
[9] J. Essigmann,et al. NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice , 2017, Proceedings of the National Academy of Sciences.
[10] M. Dizdaroglu,et al. Repair of oxidatively induced DNA damage by DNA glycosylases: Mechanisms of action, substrate specificities and excision kinetics. , 2017, Mutation research.
[11] Ruidan Ma,et al. DNA Sequence Modulates Geometrical Isomerism of the trans-8,9-Dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)-9-hydroxy Aflatoxin B1 Adduct , 2015, Chemical research in toxicology.
[12] R. Lloyd,et al. Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct. , 2014, Carcinogenesis.
[13] R. Lloyd,et al. Error-prone Replication Bypass of the Primary Aflatoxin B1 DNA Adduct, AFB1-N7-Gua* , 2014, The Journal of Biological Chemistry.
[14] J. Groopman,et al. Public health impacts of foodborne mycotoxins. , 2014, Annual review of food science and technology.
[15] S. Doublié,et al. Genome and cancer single nucleotide polymorphisms of the human NEIL1 DNA glycosylase: activity, structure, and the effect of editing. , 2014, DNA repair.
[16] M. Kew. Aflatoxins as a cause of hepatocellular carcinoma. , 2013, Journal of gastrointestinal and liver diseases : JGLD.
[17] B. Jelaković,et al. Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry. , 2013, Analytical chemistry.
[18] J. Groopman,et al. Food Safety: Mycotoxins – Occurrence and Toxic Effects , 2013 .
[19] J. Groopman,et al. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review , 2012, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
[20] J. Groopman,et al. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[21] D. V. van Thiel,et al. Non-Viral Causes of Hepatocellular Carcinoma , 2010, Journal of gastrointestinal cancer.
[22] W. Blonski,et al. Non-viral causes of hepatocellular carcinoma. , 2010, World journal of gastroenterology.
[23] M. Voehler,et al. Structural Perturbations Induced by the α-Anomer of the Aflatoxin B1 Formamidopyrimidine Adduct in Duplex and Single-Strand DNA , 2009, Journal of the American Chemical Society.
[24] R. Lloyd,et al. Human Polymorphic Variants of the NEIL1 DNA Glycosylase* , 2007, Journal of Biological Chemistry.
[25] M. Voehler,et al. Unraveling the aflatoxin-FAPY conundrum: structural basis for differential replicative processing of isomeric forms of the formamidopyrimidine-type DNA adduct of aflatoxin B1. , 2006, Journal of the American Chemical Society.
[26] J. Groopman,et al. Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry. , 2006, Chemical research in toxicology.
[27] J. Brockmöller,et al. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1. , 2006, Chemical research in toxicology.
[28] J. Groopman,et al. Role of metabolism and viruses in aflatoxin-induced liver cancer. , 2005, Toxicology and applied pharmacology.
[29] J. Groopman,et al. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk. , 2005, Cancer biomarkers : section A of Disease markers.
[30] C. Rizzo,et al. Site-specific synthesis and properties of oligonucleotides containing C8-deoxyguanosine adducts of the dietary mutagen IQ. , 2004, Journal of the American Chemical Society.
[31] J. Essigmann,et al. Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo. , 2004, Carcinogenesis.
[32] T. Massey,et al. Biotransformation of aflatoxin B x in human lung , 2004 .
[33] M. Kew. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[34] J. Essigmann,et al. The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Mitra,et al. Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Essigmann,et al. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Groopman,et al. Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats. , 2001, Chemical research in toxicology.
[38] J. Essigmann,et al. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. , 2001, Carcinogenesis.
[39] G. B. Smith,et al. Mechanisms of aflatoxin B1 lung tumorigenesis. , 2000, Experimental lung research.
[40] A. Muñoz,et al. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. , 1999, Journal of the National Cancer Institute.
[41] Fang Wang,et al. An intercalated and thermally stable FAPY adduct of aflatoxin B1 in a DNA duplex: structural refinement from 1H NMR. , 1998, Biochemistry.
[42] T. Massey,et al. Biotransformation of aflatoxin B1 in human lung. , 1996, Carcinogenesis.
[43] R. Maronpot,et al. Activation of K-ras in aflatoxin B1-induced lung tumors from AC3F1 (A/J x C3H/HeJ) mice. , 1996, Carcinogenesis.
[44] S. Griffin. DNA damage, DNA repair and disease , 1996, Current Biology.
[45] J. Essigmann,et al. Mutational properties of the primary aflatoxin B1-DNA adduct. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Groopman,et al. Repair of aflatoxin B1 DNA adducts by the UvrABC endonuclease of Escherichia coli. , 1993, The Journal of biological chemistry.
[47] C. Wild,et al. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. , 1993, Environmental health perspectives.
[48] H. Whittle,et al. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[49] J. Groopman,et al. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. , 1992, Cancer research.
[50] K. Raney,et al. Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic species , 1988 .
[51] J. Gauss,et al. Spectral and Chemical Properties of Dimethyldioxirane as Determined by Experiment and ab Initio Calculations. , 1988 .
[52] J. Gauss,et al. Spectral and chemical properties of dimethyldioxirane as determined by experiment and ab initio calculations , 1987 .
[53] V. L. Wilson,et al. Measurement of aflatoxin B1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry. , 1986, Cancer research.
[54] J. Groopman,et al. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[55] M. J. Shepherd,et al. An investigation of HPLC post-column iodination conditions for the enhancement of aflatoxin B1 fluorescence. , 1984, Food additives and contaminants.
[56] C. Chetsanga,et al. Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase. , 1983, Carcinogenesis.
[57] J. Essigmann,et al. Interactions of aflatoxin B1 and alkylating agents with DNA: structural and functional studies. , 1983, Cold Spring Harbor symposia on quantitative biology.
[58] R. C. Garner,et al. Characterisation of the imidazole ring-opened forms of trans-8,9-di-hydro-8-(7-guanyl)9-hydroxy aflatoxin B1 , 1982 .
[59] J. Groopman,et al. In vitro reactions of aflatoxin B1-adducted DNA. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[60] G. Wogan,et al. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. , 1981, Cancer research.
[61] J. Essigmann,et al. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[62] R. C. Garner,et al. Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids , 1977, Nature.
[63] J. Essigmann,et al. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[64] G. Wogan,et al. Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. , 1971, Cancer research.
[65] R. Sinnhuber,et al. Aflatoxin structure and hepatocarcinogenicity in rainbow trout (Salmo gairdneri). , 1971, Journal of the National Cancer Institute.